(Q37029155)

English

Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial

scientific article published on 27 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

0 references

author name string

Scott A Irwin

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Alana Iglewicz

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Richard A Nelesen

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Jessica Y Lo

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Connie H Carr

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sheilani D Romero

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Linda S Lloyd

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

27 June 2013

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Journal of Palliative Medicine

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

16

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

958-965

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Ketamine for depression: where do we go from here?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Ketamine as a novel antidepressant: from synapse to behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

The opportunity for psychiatry in palliative care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Beyond reliability and validity: analysis of selected quality-of-life instruments for use in palliative care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Totally implantable venous-access ports: local problems and extravasation injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Risk factors for suicide in later life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Hypodermoclysis: an alternative infusion technique.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

"Burst" ketamine for refractory cancer pain: an open-label audit of 39 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Antidepressant effects of ketamine in depressed patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Ketamine in cancer pain: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

The hospital anxiety and depression scale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

29 September 2017

Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

27 June 2018

Depression and anxiety disorders in palliative cancer care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

27 June 2018

Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

27 June 2018

Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

27 June 2018

Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patient

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

27 June 2018

On making multiple comparisons in clinical and experimental pharmacology and physiology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

27 June 2018

A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Treatment of resistant depression in patients with cancer with low doses of ketamine and desipramine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Intravenous ketamine "burst" for refractory depression in a patient with advanced cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Intravenous ketamine therapy in a patient with a treatment-resistant major depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Ketamine and the potential role for rapid-acting antidepressant medications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Successful use of ketamine for intractable cancer pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Predictors of suicide in the old elderly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Burst Ketamine to Reverse Opioid Tolerance in Cancer Pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Small-dose ketamine improves the postoperative state of depressed patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Protein binding of ketamine and its active metabolites to human serum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Low dose ketamine as an analgesic adjuvant in difficult pain syndromes: a strategy for conversion from parenteral to oral ketamine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Low doses of epidural ketamine or neostigmine, but not midazolam, improve morphine analgesia in epidural terminal cancer pain therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Ketamine: relief from chronic pain through actions at the NMDA receptor?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717203

4 September 2018

Thrombotic complications of central venous catheters in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23805864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Determinants of Suicidal Ideation and Behavior in Geriatric Depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/23805864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23805864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Group therapy and hypnosis reduce metastatic breast carcinoma pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/23805864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/23805864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practice guideline for the assessment and treatment of patients with suicidal behaviors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23805864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/23805864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report

1 reference

https://pubmed.ncbi.nlm.nih.gov/23805864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1089/JPM.2012.0617

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37029155&oldid=1672031194"